Table 5. Treatment outcome at day 90 by leishmaniasis type.
| LCLa.b N = 12 |
MCL N = 29 |
DCL N = 17 |
|||||
|---|---|---|---|---|---|---|---|
| 95% CI | 95% CI | 95% CI | P | ||||
| Cure | 4 (18.7) | 3.0–49.6 | 19 (41.7) | 12.7–76.4 | 10 (45.1) | 15.9–73.4 | 0.100 |
| Good improvement | 3 (32.8) | 2.6–83.7 | 9 (48.7) | 12.3–84.1 | 4 (31.4) | 4.7–72.2 | |
| Partial Improvement | 0 | 0 | 0 | ||||
| No improvement | 0 | 0 | 0 | ||||
| Relapse | 5 (48.4) | 6.0–91.9 | 1 (9.7) | 0.4–41.6 | 3 (23.6) | 2.8–66.0 | |
CI: confidence interval, DCL: diffuse cutaneous leishmaniasis, LCL: localized cutaneous leishmaniasis, MCL: mucocutaneous leishmaniasis.
aAll proportions shown here are adjusted by site
bPatients with leishmania recidivans are not shown in this table, as there were only two patients from Boru Meda classified as leishmania recidivans